Related Experiment Video
Updated: May 1, 2026

Modeling Charcot-Marie-Tooth Disease In Vitro by Transfecting Mouse Primary Motoneurons
Published on: January 7, 2019
Is overwork weakness relevant in Charcot-Marie-Tooth disease?
G Piscosquito1, M M Reilly2, A Schenone3
1IRCCS Foundation, C. Besta Neurological Institute, Milan, Italy.
Overwork weakness does not occur in Charcot-Marie-Tooth disease type 1A (CMT1A). Exercise and physical activity are encouraged for CMT1A patients, as muscle strength is not negatively impacted by usage.
Area of Science:
- Neurology
- Clinical Muscle Physiology
- Rehabilitation Science
Background:
- Overwork weakness (OW) is muscle weakening from exertion, known in some neuromuscular disorders.
- Its occurrence in Charcot-Marie-Tooth disease (CMT) is debated, with prior studies yielding conflicting results.
- Previous research focused on hands and did not assess lower limb muscles.
Purpose of the Study:
- To investigate the overwork weakness (OW) hypothesis in Charcot-Marie-Tooth disease type 1A (CMT1A).
- To compare bilateral muscle strength in hands and legs of CMT1A patients.
- To determine if dominant limb muscles weaken more than non-dominant ones in CMT1A.
Main Methods:
- Bilateral intrinsic hand and leg muscle strength were assessed in 271 adult CMT1A patients.
- Manual testing and manual dexterity evaluations were employed.
- Muscle strength was compared between dominant and non-dominant sides.
Main Results:
- No significant side-to-side strength differences were found for intrinsic hand muscles (first dorsal interosseous, abductor pollicis brevis) or leg muscles (anterior tibialis, triceps surae).
- Dominant muscles did not weaken with increased age or disease severity (CMT Neuropathy Score).
- The dominant triceps surae showed slightly greater strength with advancing age and disease severity.
Conclusions:
- The study data do not support the overwork weakness (OW) hypothesis in Charcot-Marie-Tooth disease type 1A (CMT1A).
- Exercise and physical activity are not detrimental and should be encouraged for CMT1A patients.
- Rehabilitation remains the primary effective treatment for managing CMT1A.
More Related Videos
06:35In Vivo Electrophysiological Measurement of Compound Muscle Action Potential from the Forelimbs in Mouse Models of Motor Neuron Degeneration
Published on: June 15, 2018
08:16Utility of Dissociated Intrinsic Hand Muscle Atrophy in the Diagnosis of Amyotrophic Lateral Sclerosis
Published on: March 4, 2014
Related Concept Videos
Myasthenia Gravis ll: Pathophysiology
Parkinson Disease ll: Pathophysiology
Disorders of the Skeletal Muscle
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Fatigue
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
Alzheimer Disease ll: Pathophysiology